BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34234877)

  • 21. Axial spondyloarthritis and inflammatory bowel disease: association between disease activity and endothelial dysfunction markers.
    Przepiera-Będzak H; Fischer K; Brzosko M
    Rheumatol Int; 2022 Feb; 42(2):273-277. PubMed ID: 34240250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could C-Reactive Protein/Albumin Ratio be an Indicator of Activation in Axial Spondyloarthritis?
    Pamukcu M; Duran TI
    J Coll Physicians Surg Pak; 2021 May; 31(5):537-541. PubMed ID: 34027865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epicardial adipose tissue thickness and growth differentiation factor 15 in axial spondyloarthritis: A cross-sectional study.
    Okçu M; Koçak FA; Şaş S; Güçlü K
    Saudi Med J; 2022 Sep; 43(9):1020-1026. PubMed ID: 36104054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis.
    Siebuhr AS; Hušaková M; Forejtová S; Zegzulková K; Tomčik M; Urbanová M; Grobelná K; Gatterová J; Bay-Jensen AC; Pavelka K
    Clin Exp Rheumatol; 2019; 37(3):358-366. PubMed ID: 30767876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can whole spine magnetic resonance imaging predict radiographic progression and inflammatory activity in axial spondyloarthritis?
    Kim JG; Jung JY; Lee J; Kwok SK; Ju JH; Park SH; Kim WU
    Joint Bone Spine; 2022 Jul; 89(4):105352. PubMed ID: 35124211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
    Kang KY; Ju JH; Park SH; Hong YS
    J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring complement biomarkers in suspected axial spondyloarthritis.
    Mistegård CE; Troldborg A; Loft AG; Thiel S; Spiller L; Protopopov M; Rios Rodriguez V; Muche B; Rademacher J; Weber AK; Lüders S; Sieper J; Poddubnyy D; Proft F
    RMD Open; 2024 May; 10(2):. PubMed ID: 38749532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between Vitamin D levels and pain and disease activity in patients with newly diagnosed axial spondyloarthritis.
    Deng S; He Y; Nian X; Sun E; Li L
    Int J Nurs Sci; 2020 Jan; 7(1):54-59. PubMed ID: 32099860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
    Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
    Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Biomarker of Collagen Degradation Can Identify Patients Affected With Both Axial Spondyloarthritis and Crohn Disease.
    Nielsen SH; Stahly A; Regner EH; Bay-Jensen AC; Karsdal MA; Kuhn KA
    J Rheumatol; 2022 Dec; 49(12):1335-1340. PubMed ID: 35705233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.
    Stebbings SM; Treharne GJ; Jenks K; Highton J
    Clin Rheumatol; 2014; 33(10):1467-74. PubMed ID: 24322832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.
    Akgul O; Bodur H; Ataman S; Yurdakul FG; Capkin E; Gurer G; Sezer I; Duruoz MT; Melikoglu MA; Cay HF; Rezvani A; Yagci I; Gogus F; Kamanli A; Cevik R
    Rheumatol Int; 2020 Nov; 40(11):1793-1801. PubMed ID: 32814986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and anxiety in individuals with axial spondyloarthritis and nonspecific low back pain who are interested in non-pharmacological therapy options: Cross-sectional study.
    Hušáková M; Levitová A; Domluvilová D; Dad'ová K; Pavelka K
    Medicine (Baltimore); 2022 Sep; 101(39):e30866. PubMed ID: 36181028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of non-radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data.
    Jeong H; Kim YG; Kim TH; Kim TJ; Park MC; Seo MR; Shin K; Oh JS; Lee SH; Lee YA; Lee EY; Baek HJ; Cha HS
    Int J Rheum Dis; 2021 Sep; 24(9):1137-1147. PubMed ID: 34250745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.
    Ciurea A; Scherer A; Weber U; Exer P; Bernhard J; Tamborrini G; Riek M; Müller RB; Weiss B; Nissen MJ; Kissling R; Michel BA; Finckh A;
    Ann Rheum Dis; 2016 Mar; 75(3):532-9. PubMed ID: 25667205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
    Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L
    Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.
    Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M
    Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.